Chemical Structure : Sapanisertib
CAS No.: 1224844-38-5
货号: PC-43497Not For Human Use, Lab Use Only.
Sapanisertib (INK-128, MLN0128, TAK-228) is a potent, ATP-competitive, orally active dual mTORC1/2 inhibitor with Ki of 1.4 nM in cell-free assays, >200-fold selectivity over calss I PI3K isoforms.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥1780 | In stock | |
100 mg | ¥3880 | In stock | |
500 mg | ¥8480 | In stock | |
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Sapanisertib (INK-128, MLN0128, TAK-228) is a potent, ATP-competitive, orally active dual mTORC1/2 inhibitor with Ki of 1.4 nM in cell-free assays, >200-fold selectivity over calss I PI3K isoforms.
Sapanisertib (INK-128, MLN0128) inhibits both the phosphorylation of S6 and 4EBP1, the downstream substrates of TORC1, and selectively inhibits AKT phosphorylation at Ser473, the downstream substrate of TORC2.
Sapanisertib (INK-128, MLN0128) also shows potent inhibition effects on cell lines resistant to rapamycin and pan-PI3K inhibitors.
Sapanisertib (INK-128, MLN0128) shows tumor growth inhibition efficacy in multiplexenograft models.
分子量 | 309.33 | |
分子式 | C15H15N7O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)- |
1. Hsieh AC, et al. Nature. 2012 Feb 22;485(7396):55-61.
2. Gökmen-Polar Y, et al. Breast Cancer Res Treat.
3. Maiso P, et al. Blood. 2011 Dec 22;118(26):6860-70.
4. Janes MR, et al. Leukemia. 2013 Mar;27(3):586-94.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright